British Doctors Lead Innovation in Male Enhancement with Peer-Reviewed Research

Editorial Brief
At a glance: AI-assisted overview, optimised for journalists, search & news aggregators
Press Release

Aiva Wellness, a leading luxury medical aesthetics clinic in Mayfair, London, announces a major milestone in the field of male enhancement. Founders Dr. Sef and Dr. Raheem are the first British doctors to have their groundbreaking work in penile filler augmentation officially published in peer-reviewed medical journals, establishing a new clinical standard in this emerging space.

Their research focuses on aiva® Hybrid-Ultimate, a regenerative solution designed for men seeking enhancement without surgery. This innovative treatment, part of a growing category often referred to as penis filler, offers a safe, minimally invasive option with natural-looking, long-term results. Its publication reinforces the scientific credibility and efficacy behind Aiva’s approach to male aesthetics.

“Our goal has always been to provide discreet, medically sound treatments that help men feel more confident,” said Dr. Sef, who invented the Hybrid-Ultimate filler. “Having our work peer-reviewed brings transparency and trust to a space that has often lacked both.”

The Aiva team also developed aiva® RE-VERSE, a powerful regenerative anti-ageing injectable. With over a decade of experience, the clinic has earned a trusted reputation among high-profile clients including CEOs, athletes, and public figures who value excellence, privacy, and natural enhancement.

About Aiva Wellness

Aiva Wellness is a high-end, doctor-led medical aesthetics clinic based in London’s Mayfair district. The clinic specializes in regenerative injectable treatments with a focus on male enhancement, facial harmony, and anti-ageing solutions. Every procedure is grounded in science, clinical expertise, and a bespoke approach.

Get more news like this

Get more news like this on Google. Set News By Wire as a ‘Preferred News Source’ to get quicker access to news that’s important.

All done!
Thank you for subscribing.

Email Subscription